Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry (NCT06932081)
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i (ACHIEVE-SGLT2i) Registry
🩺 Plain-English Summary (8th-Grade Level)
This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.
Who can join: Review the eligibility criteria below.
Location: Johns Hopkins University — Baltimore, Maryland
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Johns Hopkins University — Baltimore, Maryland
- Helen DeVos Children's Hospital — Grand Rapids, Michigan
- Mount Sinai Fuster Heart Hospital — New York, New York
- Heart Center Duisburg (Evangelical Hospital Niederrhein) — Duisburg,
- Leiden University Medical Center (LUMC) — Leiden, South Holland
- Amsterdam University Medical Center — Amsterdam,
- University Medical Center Utrecht — Utrecht,
- Zan Mitrev Clinic — Skopje,
- University Hospital of Wales — Cardiff,
- Golden Jubilee University National Hospital — Glasgow,
- Barts Heart Centre — London,
📞 Contact the Study Coordinator
Phone: +31 71 5262020
Email: r.m.l.neijenhuis@lumc.nl
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Adult Congenital Heart Disease
- Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders — Cincinnati, Ohio
- Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease — Pittsburgh, Pennsylvania
- Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease — Washington D.C., District of Columbia
Explore by condition: All Adult Congenital Heart Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.